Bystolic: new beta-blocker for hypertensionForest Laboratories will soon launch a new once-daily beta-blocker for the treatment of mild to moderate essential hypertension. Say what? Nurses spend too much time chatting: U.K.'s new patient tsarAnn Clwyd, a Labour MP advising the Coalition, has received thousands of letter from people worried about the poor care of their relatives in NHS hospitals. Federal funding set for personalized health research projects OTTAWA | Canadians with debilitating diseases will soon benefit from new personalized approaches to treatment thanks to Canadian research and government funding. Our own devices Canada could be a world leader in developing, manufacturing and exporting medical devices. Why are we not? Leading Edge: Solid tumour smackdown Leading Edge: PC partner Leading Edge: Do your own antibody testing, and save Slow growth for vitamins and minerals In the multivitamin category, growth is driven by gender-specific offerings Energy sector adds oomph to OTC sales Innovation drives natural health products The drug channel owns about 54% of the total nutritive market, which includes vitamins, minerals, single herbals and nutritional supplements First Previous 579 580 581 582 583 Next Last
